Speakers

 

 

Key Speakers

Lord James (Jim) O’Neil, Honorary Professor of Economics at the University of Manchester & author of AMR review UK Lord James (Jim) O’Neil
Honorary Professor of Economics
University of Manchester & Author of AMR Review UK

Ana Maria Henao-Restrepo MD, Team Leader, Implementation Research Initiative for Vaccine Research, WHO Ana Maria Henao-Restrepo MD
Team Leader, Implementation Research Initiative for Vaccine Research
WHO

Emily Erbelding, M.D., M.P.H., Director, Division of Microbiology and Infectious Diseases, NIAID/NIH Emily Erbelding
M.D., M.P.H., Director, Division of Microbiology and Infectious Diseases
NIAID/NIH

Dr Melanie Saville, Director of Vaccine Development, CEPI Dr Melanie Saville
Director of Vaccine Development
CEPI

Dr Thomas G. Evans, CEO, Vaccitech Dr Thomas G. Evans
CEO
Vaccitech

Dr Laszlo Radvanyi, Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology, EMD Serono Dr Laszlo Radvanyi
Senior Vice President & Senior Global Scientific Advisor, Immuno-Oncology
EMD Serono

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines Dr Rino Rappuoli
Chief Scientist
GSK Vaccines

Ruxandra Draghia-Akli, Vice President of Vaccines Public Health & Scientific Affairs, Merck (MSD) Ruxandra Draghia-Akli
Vice President of Vaccines Public Health & Scientific Affairs
Merck (MSD)

Dr Wayne Koff, President & CEO, The Human Vaccines Project Dr Wayne Koff
President & CEO
The Human Vaccines Project

Professor Helen McShane, Professor of Vaccinology, Jenner Institute, Oxford University Professor Helen McShane
Professor of Vaccinology, Jenner Institute
Oxford University

Agenus Inc Dr Alex Duncan
Chief Technology Officer and Head of Research
Agenus Inc

 

 

 

2018 CONFIRMED SPEAKERS

 

Dr Dicky Abraham, Executive Director/Distinguished Scientist, Merck, United States

Prof Jeffrey Almond, Former Vice President Discovery Research and Development, Sanofi and Visiting Professor, University of Oxford - Oxford Vaccine Group, United Kingdom

Jonas Anders, Associate Director - Sales Development Purification Eastern, Merck Group, Germany

Jonas Anders at World Vaccine Congress Europe

Dr Annaliesa Anderson, Vice President and CSO Bacterial Vaccines, Pfizer, United States

Dr Jean-Christophe Audonnet, Senior Director, Research Strategy and Key Alliances, Bio R&D and Coordinatior at ZAPI, Merial, France

Dr Jean-Christophe Audonnet at World Vaccine Congress Europe

Dr Joeri Auwerx, Director, Discovery Research, ViroVet N.V., Belgium

Dr Joeri Auwerx at World Vaccine Congress Europe

Dr Lorne Babiuk, Former Vice President Research, University of Alberta, Canada

Dr Frank Baehner, Area Head Prophylactic Vaccines, CureVac, Switzerland

Dr Tamar Ben Yedidia, Chief Scientific Officer, Biondvax Pharmaceuticals Ltd, Israel

Dr Todd Black, Executive Director, Infectious Diseases, Merck Research Laboratory, United States

Prof Marc Bonten, Professor, UMC Utrecht, Netherlands

Prof Marc Bonten at World Vaccine Congress Europe

Prof Anne Botteaux, Molecular Bacteriology Laboratory, Universite Libre De Bruxelles, Belgium

Prof Anne Botteaux at World Vaccine Congress Europe

Dr Anissa Boumlic-Courtade, Vaccine Market Lead, EMEA, MERCK, France

Dr Helen Bright, Head, Team of Cell and Molecular Biologics, MedImmune, United Kingdom

Dr Helen Bright at World Vaccine Congress Europe

Dr Rosario Bullido, Head of Veterinary Inmunological Medicines Assessment Unit Veterinary Medicines Department, Aemps, Spain

Dr Rosario Bullido at World Vaccine Congress Europe

Dr Miles Carroll, Deputy Director, Public Health England, United Kingdom

Dr Manuel Carrondo, Vice President, IBET, Portugal

Dr Manuel Carrondo at World Vaccine Congress Europe

Dr Senyon Choe, President of Mogam Institute for Biomedical Research & Professor, UCSD, United States

Prof Dennis Christensen, Head of Vaccine Adjuvant Research grp., Dept. Infectious Disease Immunology, Statens Serum Institute - Denmark, Denmark

Dr Ralf Clemens, SVP, Grid Rio, Germany

Dr Ralf Clemens at World Vaccine Congress Europe

Dr Jeffrey Cohen, Chief of Laboratory of Infectious Diseases, NIH, United States

Dr Jeffrey Cohen at World Vaccine Congress Europe

Professor Louise Cosby, Head of Virology, Agri-Food and Biosciences Institute, United Kingdom

Prof Ron Dagan, head, pediatric Infectious diseases, Ben Gurion University, Israel

Eduardo de Gomensoro, Director, Global Medical Affairs Lead, Zoster, GSK, United States

Eduardo de Gomensoro at World Vaccine Congress Europe

Dr Dimitri Diavatopoulos, Department of Pediatrics/ Laboratory of Pediatric Infectious Diseases (LPID), Radboud University Medical Center, Netherlands

Dr Dimitri Diavatopoulos at World Vaccine Congress Europe

Dr Ruxandra Draghia Akli, Vice President, Public Health and Scientific Affairs, MSD, Belgium

Dr Philippe Duchateau, Chief Scientific Officer, Cellectis, France

Dr Alex Duncan, Chief Technology Officer and Head of Research, Agenus Inc, United States

Dr Emily Erbelding, Director, DMID, National Institutes of Health, United States

Dr Emily Erbelding at World Vaccine Congress Europe

Dr Thomas G. Evans, Vaccitech, United Kingdom

Dr Thomas G. Evans at World Vaccine Congress Europe

Dr Ali Fattom, Sr. VP of Vaccines Research and Development, NanoBio Corporation, United States

Dr Tony Fooks, Head of Wildlife Zoonoses and Vector-Borne Diseases Research Group, Animal Health and Veterinary Laboratories Agency, United Kingdom

Dr Tony Fooks at World Vaccine Congress Europe

Dr Martin Friede, Coordinator, Initiative for Vaccine Research Immunization, Vaccines and Biologicals Department, WHO, Switzerland

Dr Nathalie Garcon, CEO/CSO, BIOASTER, Belgium

Christiane Gerke, Head of Vaccine Programs, Institut Pasteur, France

Christiane Gerke at World Vaccine Congress Europe

Sarah Gilbert, Professor of Vaccinology, University of Oxford, United Kingdom

Dr David Gilham, Vice President of Research and Development, Celyad, Belgium

Dr Gregory Glenn, President, Research and Development, Novavax, United States

Dr Farshad Guirakhoo, CSO, GeoVax, Inc., United States

Dr Farshad Guirakhoo at World Vaccine Congress Europe

Dr Bassam Hallis, Head of Pre Clinical Development and General Project Manager, Public Health England, United Kingdom

Dr Bassam Hallis at World Vaccine Congress Europe

Prof Mark Hatherill, Professor, S.A. Tuberculosis Vaccine Initiative, South Africa

Prof Mark Hatherill at World Vaccine Congress Europe

Professor John Hayball, Professor, University of South Australia, Australia

Professor John Hayball at World Vaccine Congress Europe

Professor Peter M H Heegaard, Professor, National Veterinary Institute Technical University of Denmark, Denmark

Ana Maria Henao Restrepo, Implementation Research and Economic Analysis, Initiative for Vaccine Research, World Health Organization, Switzerland

Dr Hanjo Hennemann, Chief Scientific Officer and Co Founder, VEROVACCiNES, Germany

David Hipkiss, Chief Executive Officer, Enesi Pharma Limited, United Kingdom

Dr Karin Hoelzer, Senior Officer, Pew Charitable Trusts, United States

Marc Hoffman, CMO, Celerion, Germany

Dr Mark Howarth, Professor, University of Oxford, United Kingdom

Professor Dirk Jager, Managing Director, University Hospital of Heidelberg, Germany

Professor Dirk Jager at World Vaccine Congress Europe

Dr Jan Jezek, Chief Scientific Officer, Arecor Ltd, United Kingdom

Professor Lana Kandalaft, Director, Center of Experimental Therapeutics, University of Lausanne, Switzerland

Dr Maria Karasarides, Executive Director, ImmunoOncology, Regeneron Pharmaceuticals, United States

Dr Maria Karasarides at World Vaccine Congress Europe

Dr Joseph Kim, Chief Executive Officer, Inovio Pharmaceuticals, United States

Olivier Kitten, Chief Executive Officer, Affilogic, France

Dr Wayne C Koff, President and CEO, The Human Vaccines Project, United States

Dr Alexander Kort, Head Of Business Processes & Quality, Themis Bioscience GmbH, Austria

Professor Jeroen Kortekaas, PhD, Virologist/Group Leader, Central Veterinary Institute, part of Wageningen UR, Netherlands

Dr Trevor Lawley, Group Leader, Wellcome Trust Sanger Institute Genome Research Ltd, United Kingdom

Dr Trevor Lawley at World Vaccine Congress Europe

Dr Yotam Levin, Chief Executive Officer, NanoPass Technologies, Israel

Bernhard Liegl, VP Global Clinical Development, Celerion, Germany

Dr Michael Makanga, Executive Director, European and Developing Countries Clinical Trials Partnership, Netherlands

Dr Michael Manns, Professor, Hannover Medical School, Germany

Dr Michael Manns at World Vaccine Congress Europe

Dr Douglas Mcneel, Chief Scientific Founder and Head of M.V.I. Scientific Advisory Board, Madison Vaccines Inc., United States

Professor Helen Mcshane, Professor Of Vaccinology Wellcome Senior Fellow PI Head Of TB Vaccines Group, Jenner Institute University of Oxford, United Kingdom

Professor Helen Mcshane at World Vaccine Congress Europe

Dr Kees Melief, Chief Scientific Officer, I.S.A. Pharmaceuticals, Netherlands

Dr Matthias Miller, Senior Project Manager, BioNTech Ag, Germany

Prof Kingston H.G. Mills, Professor of Experimental Immunology, Trinity College Dublin, Ireland

Prof Emanuele Montomoli, Prof in Public Health University of Siena & CSO, VisMederi, Italy

Jeffrey Moore, President, MP Healthcare Venture, United States

Dr Tarit Mukhopadhyay, Senior Lecturer of Vaccine Bioprocess Development, University College London, United Kingdom

Dr Mel Munro, Project Manager, Biologicals Regulatory Affairs, Triveritas Limited, United Kingdom

Dr Mel Munro at World Vaccine Congress Europe

Mikkel Nissum, Technical Development Leader, GSK Vaccine, Italy

Mikkel Nissum at World Vaccine Congress Europe

Professor Hanna Nohynek, Deputy Director, National Institute for Health and Welfare, Finland

Professor Hanna Nohynek at World Vaccine Congress Europe

Lord James (Jim) O’Neil, Honorary Professor of Economics at the University of Manchester & author of AMR review UK, The University Of Manchester, United Kingdom

Lord James (Jim) O’Neil at World Vaccine Congress Europe

Prof Ab Osterhaus, Director, Research Center for Emerging Infections and Zoonoses (RIZ), University of Veterinary Medicine Hannover, Netherlands

Dr Cristina Peixoto, Head of Downstream Process A.C.T.U., I.B.E.T., Portugal

Dr Misha Petkevich, Chief Investment Officer, V2M Capital LLC, United States

Ivo Ploemen, Business Development manager, Intravacc, Netherlands

Dr Gregory A. Poland, Director of Mayo Vaccine Research Group, Mayo Clinic and Foundation, United States

Dr Jan Poolman, Head Bacterial Vaccine Discovery and Early Development, Janssen, Netherlands

Prof Roman Prymula, Professor Preventive Medicine, Charles University in Prague, Czech Republic

Prof Roman Prymula at World Vaccine Congress Europe

Dr Laszlo Radvanyi, Senior Vice President, Senior Scientific Advisor, EMD Serono, United States

Dr Laszlo Radvanyi at World Vaccine Congress Europe

Dr Rino Rappuoli, Chief Scientist, GSK Vaccines, United States

Amelie Raveneau, Vaccine Platform Manager, Sartorius Stedim Biotech, France

Prof Robert Read, Head of Academic Unit - Clinical and Experimental Sciences, Professor of Infectious Diseases, Honorary Consultant Physician, University of Southampton, United Kingdom

Antonio Roldao, Senior Researcher, I.B.E.T., Portugal

Dr Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Infectious Diseases and Vaccines, United States

Dr Jeremy Salt, Chief Scientific Officer, Galvmed, United Kingdom

Dr Jeremy Salt at World Vaccine Congress Europe

Dr Adel Samson, Lead, Translational Cancer Immunotherapy Group, University of Leeds, United Kingdom

Dr Adel Samson at World Vaccine Congress Europe

Dr Melanie Saville, Director Vaccine Development, CEPI, France

Dr Joerg (Jörg) Schwinde, Eppendorf Inc., Malaysia

Dr Joerg (Jörg) Schwinde at World Vaccine Congress Europe

Dr Ruud Segers, Executive Director, Clinical Research & Head Global Swine Biologicals R&D, MSD Animal Health, Netherlands

Pei-Yong Shi, Kempner Professor of Human Genetics, University of Texas Medical Branch, United States

Dr Katherine Shives, R&D Scientist, Sartorius-Stedim-Biotech, United States

Bruno Speder, Head of Clinical Regulatory Affairs, SGS – Life Science Services, Belgium

Bruno Speder at World Vaccine Congress Europe

Dr Daniel Speiser, Head of Clinical Tumour Biology and Immunotherapy Group, University of Lausanne, Switzerland

Dr Daniel Speiser at World Vaccine Congress Europe

Prof D.E. Speiser, Medicine and Research, Ludwig Cancer Research Ctr, Switzerland

Dr Peter Timmerman, Chief Scientific Officer, Pepscan Therapeutics, Netherlands

Dr Peter Timmerman at World Vaccine Congress Europe

Dr Lincoln Tubbs, Director, Food Animal Vaccines R&D, Elanco Animal Health, United States

Dr Jeffrey Ulmer, Head, Preclinical R&D US, GSK Vaccines, United States

Dr Alicia Urniza, Senior Director EU Biologicals, Veterinary Medicine R&D Global Biologics, Zoetis, Belgium

Dr Joris Vandeputte, President, IABS, Belgium

Dr Arne Von Bonin, Chief Scientific Officer, Vaxxilon Ag, Switzerland

Professor Mark Wilcox, Professor of Medical Microbiology & Deputy-Chair, APRHAI, University of Leeds, United Kingdom

Professor Mark Wilcox at World Vaccine Congress Europe

Dr Adrian Wildfire, Project Director - Infectious Diseases & Viral Infection Unit, SGS Life Science Services, Switzerland

Dr Adrian Wildfire at World Vaccine Congress Europe

Dr Paul Williams, Technical Manager, MSD Animal Health, United Kingdom

Dr Richard Wyatt, Professor of Immunology and Director Viral Immunology, The Scripps Research Institute, United States of America

Dr Richard Wyatt at World Vaccine Congress Europe

Dr Giovanna Zanoni, Assistant Director, Immunology Unit, University Hospital in Verona Italy, Italy

Fred Zepp, Medical Director and Chairman of the Department of Paediatrics, University Medicine Mainz, Germany

Fred Zepp at World Vaccine Congress Europe

Glen Zimmermann, Senior Director Business Development, West Pharmaceutical Services, Israel

Glen Zimmermann at World Vaccine Congress Europe

Dr Mai-Britt Zocca, Chief Executive Officer and Founder, IO Biotech ApS, Denmark

Dr Alfredo Zurlo, Chief Medical Officer, Glycotope, Germany

 

 

Sign Up for Event Updates